Pfizer RSV vaccine protects older adults over two seasons
Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesPfizer's vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday.The shot's efficacy declined slightly compared with the levels of protection after one RSV...